← Evidence map

ArticleBioactive materials2024

Corrigendum to "Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia" [Bioact. Mater. 21 (March 2023) 499-510].

Yifeng Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 37637085